MSLN and neoplasm: The allogenic tumor lysate is an ‘off-the-shelf’ product composed of several TAAs, generated from malignant mesothelioma cell lines, containing shared antigens with PDAC, including mesothelin (MSLN), WT1, and Survivin [56].